Robert Califf’s confirmation as FDA commissioner clears Senate HELP Committee

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Senate Health, Education, Labor, and Pension Committee voted 13-8 to confirm Robert Califf as the next commissioner of FDA. 

Next, Califf’s candidacy goes to the full Senate.

Table of Contents

YOU MAY BE INTERESTED IN

FDA accepted a new drug application and granted priority review designation for the investigational compound sevabertinib (BAY 2927088), an oral, small molecule, tyrosine kinase inhibitor, for the treatment of adult patients with advanced non-small cell lung cancer whose tumors have activating human epidermal growth factor receptors 2 (HER2) (ERBB2) mutations and who have received a prior systemic therapy.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login